Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Abnormal TP53 predicts risk of progression in patients with Barrett’s esophagus regardless of a diagnosis of dysplasia

Mark Redston, Amy Noffsinger, Anthony Kim, Fahire G Akarca, Diane Stapleton, Laurel Nowden, Richard Lash, Adam J Bass, View ORCID ProfileMatthew D Stachler
doi: https://doi.org/10.1101/2020.10.18.20213561
Mark Redston
1Department of Pathology, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts, USA
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: mredston{at}partners.org Matthew.Stachler{at}UCSF.edu
Amy Noffsinger
2Inform Diagnostics, Irving, Texas, USA
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anthony Kim
3Department of Molecular Oncology, Dana Farber Cancer Institute, Boston, Massachusetts, USA
BS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fahire G Akarca
3Department of Molecular Oncology, Dana Farber Cancer Institute, Boston, Massachusetts, USA
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Diane Stapleton
2Inform Diagnostics, Irving, Texas, USA
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Laurel Nowden
2Inform Diagnostics, Irving, Texas, USA
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Richard Lash
4R Lash MD, LLC, Southlake, TX, USA
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Adam J Bass
3Department of Molecular Oncology, Dana Farber Cancer Institute, Boston, Massachusetts, USA
5Eli and Edythe L. Broad Institute, Cambridge, Massachusetts, USA
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthew D Stachler
6Department of Pathology, University of California San Francisco, San Francisco, CA, USA
MD,PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Matthew D Stachler
  • For correspondence: mredston{at}partners.org Matthew.Stachler{at}UCSF.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Data Availability

All data within the manuscript is available either within the manuscript or through communication with the authors.

Back to top
PreviousNext
Posted October 21, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Abnormal TP53 predicts risk of progression in patients with Barrett’s esophagus regardless of a diagnosis of dysplasia
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Abnormal TP53 predicts risk of progression in patients with Barrett’s esophagus regardless of a diagnosis of dysplasia
Mark Redston, Amy Noffsinger, Anthony Kim, Fahire G Akarca, Diane Stapleton, Laurel Nowden, Richard Lash, Adam J Bass, Matthew D Stachler
medRxiv 2020.10.18.20213561; doi: https://doi.org/10.1101/2020.10.18.20213561
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Abnormal TP53 predicts risk of progression in patients with Barrett’s esophagus regardless of a diagnosis of dysplasia
Mark Redston, Amy Noffsinger, Anthony Kim, Fahire G Akarca, Diane Stapleton, Laurel Nowden, Richard Lash, Adam J Bass, Matthew D Stachler
medRxiv 2020.10.18.20213561; doi: https://doi.org/10.1101/2020.10.18.20213561

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Pathology
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)